References
- Tanaka T, Decuzzi P, Cristofanilli M et al. Nanotechnology for breast cancer therapy. Biomed. Microdevices11(1), 49–63 (2009).
- Yezhelyev MV, Gao X, Xing Y, Al Hajj A, Nie S, O’Regan RM. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol.7(8), 657–667 (2006).
- Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer5(3), 161–171 (2005).
- Wang X, Yang L, Chen ZG, Shin DM. Application of nanotechnology in cancer therapy and imaging. CA Cancer J. Clin.58(2), 97–110 (2008).
- Jain KK. Applications of nanobiotechnology in clinical diagnostics. Clin. Chem.53(11), 2002–2009 (2007).
- Yezhelyev MV, Al Hajj A, Morris C et al.In situ molecular profiling of breast cancer biomarkers with multicolor quantum dots. Adv. Materials19, 3146–3151 (2007).
- Xing Y, Chaudry Q, Shen C et al. Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Nat. Protoc.2(5), 1152–1165 (2007).
- Xiao Y, Telford WG, Ball JC, Locascio LE, Barker PE. Semiconductor nanocrystal conjugates, FISH and pH. Nat. Methods2(10), 723 (2005).
- Song KH, Kim C, Maslov K, Wang LV. Noninvasive in vivo spectroscopic nanorod-contrast photoacoustic mapping of sentinel lymph nodes. Eur.J. Radiol.70(2), 227–231 (2009).
- Tada H, Higuchi H, Wanatabe TM, Ohuchi N. In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. Cancer Res.67(3), 1138–1144 (2007).
- Artemov D, Mori N, Okollie B, Bhujwalla ZM. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn. Reson. Med.49(3), 403–408 (2003).
- Zhou J, Leuschner C, Kumar C, Hormes JF, Soboyejo WO. Sub-cellular accumulation of magnetic nanoparticles in breast tumors and metastases. Biomaterials27(9), 2001–2008 (2006).
- Sunderland CJ, Steiert M, Talmadge JE, Derfus AM, Barry SE. Targeted nanoparticles for detecting and treating cancer. Drug Dev. Res.67, 70–93 (2006).
- Pan D, Lanza GM, Wickline SA, Caruthers SD. Nanomedicine: perspective and promises with ligand-directed molecular imaging. Eur. J. Radiol.70(2), 274–285 (2009).
- Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol.2(12), 751–760 (2007).
- Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther.83(5), 761–769 (2008).
- Weng KC, Noble CO, Papahadjopoulos-Sternberg B et al. Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo. Nano. Lett.8(9), 2851–2857 (2008).
- Prabha S, Labhasetwar V. Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. Mol. Pharm.1(3), 211–219 (2004).
- Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther.12(5), 461–466 (2005).
- Hirsch LR, Stafford RJ, Bankson JA et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl Acad. Sci. USA100(23), 13549–13554 (2003).
- Shao N, Lu S, Wickstromand E, Panchapakesan B. Integrated molecular targeting of IGF1R and HER2 surface receptors and destruction of breast cancer cells using single wall carbon nanotubes. Nanotechnology18, 315101 (2007).
Websites
- NICE. Advanced breast cancer: diagnosis and treatment www.nice.org.uk
- Cancer incidence and mortality: trends in the UK and constituent countries www.statistics.gov.uk
- Cancer research UK www.cancerresearchuk.org
- NICE. Early and locally advanced breast cancer: diagnosis and treatment www.nice.org.uk
- Technology Transfer Centre. Government funding, companies and applications in nanotechnology worldwide www.nano.org.uk/reports.htm
- National Cancer Institute www.cancer.gov